Clobbering Purdue Pharma Makes Drug Warriors Feel Good, but It Won’t Reduce Opioid-Related Deaths
The U.S. Department of Justice today announced an $8.3 billion settlement with OxyContin manufacturer Purdue Pharma, which admitted to lax anti-diversion practices that allowed doctors and pharmacies to distribute its …